SCHEMBL2226017

SCHEMBL2226017

CS(=O)(=O)c1ccc(S(N)(=O)=O)cc1CNc1cc(Nc2ccc(C#N)cn2)ncn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 4/20 0.43
TNNI3K Q59H18 2/20 0.43
IDH1 O75874 3/20 0.41
TYK2 P29597 2/20 0.39
CDK1 P06493 1/20 0.38
CCNB1 P14635 1/20 0.38
CCNA2 P20248 1/20 0.38
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
CHEK1 O14757 2/20 0.36
IRAK4 Q9NWZ3 3/20 0.36
EGFR P00533 1/20 0.34
ERBB3 P21860 1/20 0.34
CCR6 P51684 2/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2226542 0.90 CCNA2 (0.48) TNNI3KCDK1CCNB1CCNA2CCNE1
SCHEMBL2226261 0.87 TNNI3K (0.58) BRAFTNNI3KIDH1CDK1CCNB1
SCHEMBL2226948 0.81 BRAF (0.48) BRAFTNNI3KIDH1CDK1CCNB1
SCHEMBL2226380 0.80 CCNA2 (0.47) TNNI3KTYK2CDK1CCNB1CCNA2
SCHEMBL2227374 0.79 CDK1 (0.51) BRAFTNNI3KCDK1CCNB1CCNA2
SCHEMBL2225212 0.78 EGFR (0.46) TNNI3KCDK1CCNB1CCNA2CCNE1
SCHEMBL2227169 0.78 CDK1 (0.40) BRAFTNNI3KCDK1CCNB1CCNA2
SCHEMBL2225414 0.77 CDK1 (0.46) BRAFTNNI3KCDK1CCNB1CCNA2
SCHEMBL2226032 0.77 BRAF (0.60) BRAFTNNI3KIDH1CDK1CCNB1
SCHEMBL2225921 0.76 CDK1 (0.42) BRAFTNNI3KCDK1CCNB1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP claimed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO claimed
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed